NanoVibronix Files 8-K for Disclosures and Exhibits
Ticker: FEED · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1326706
| Field | Detail |
|---|---|
| Company | Nanovibronix, Inc. (FEED) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: NVBX
TL;DR
NVBX filed an 8-K, mostly procedural stuff, check exhibits for details.
AI Summary
NanoVibronix, Inc. filed an 8-K on December 19, 2024, to report on Regulation FD disclosures and to file financial statements and exhibits. The filing does not contain specific financial figures or material events beyond the procedural reporting of these items.
Why It Matters
This filing indicates NanoVibronix is adhering to regulatory requirements for reporting financial information and other disclosures to the public.
Risk Assessment
Risk Level: low — The filing is a routine procedural update and does not contain new material information that would immediately impact the company's risk profile.
Key Players & Entities
- NanoVibronix, Inc. (company) — Registrant
- December 19, 2024 (date) — Date of earliest event reported
- 969 Pruitt Ave, Tyler, Texas 77569 (address) — Principal executive offices
- (914) 233-3004 (phone_number) — Registrant's telephone number
FAQ
What specific items are being disclosed under Regulation FD?
The filing states it is for Regulation FD Disclosure, but the specific content of the disclosure is not detailed within the provided text, requiring examination of the attached documents.
What financial statements and exhibits are being filed?
The filing indicates that Financial Statements and Exhibits are being filed, but their specific content is not listed in this summary section.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on December 19, 2024.
What is the principal executive office address for NanoVibronix, Inc.?
The principal executive offices are located at 969 Pruitt Ave, Tyler, Texas 77569.
What is the company's SIC code and industry classification?
The company's Standard Industrial Classification (SIC) code is 3842, which falls under 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.
Filing Stats: 546 words · 2 min read · ~2 pages · Grade level 11.9 · Accepted 2024-12-19 10:13:40
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share NAOV Nasdaq Capital Mark
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 111KB
- ex99-1_002.jpg (GRAPHIC) — 272KB
- ex99-1_003.jpg (GRAPHIC) — 253KB
- ex99-1_004.jpg (GRAPHIC) — 250KB
- ex99-1_005.jpg (GRAPHIC) — 209KB
- ex99-1_006.jpg (GRAPHIC) — 180KB
- ex99-1_007.jpg (GRAPHIC) — 190KB
- ex99-1_008.jpg (GRAPHIC) — 163KB
- ex99-1_009.jpg (GRAPHIC) — 335KB
- ex99-1_010.jpg (GRAPHIC) — 301KB
- ex99-1_011.jpg (GRAPHIC) — 176KB
- ex99-1_012.jpg (GRAPHIC) — 169KB
- 0001493152-24-050712.txt ( ) — 3811KB
- naov-20241219.xsd (EX-101.SCH) — 3KB
- naov-20241219_lab.xml (EX-101.LAB) — 33KB
- naov-20241219_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure . NanoVibronix, Inc. (the "Company") is furnishing a copy of the presentation materials presented by Brian Murphy, the Company's chief executive officer, at the Company's Annual Meeting of Stockholders on December 19, 2024. A copy of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company undertakes no obligation to update, supplement or amend the materials attached hereto. The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is being furnished pursuant to Item 7.01 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 2024 Annual Stockholder Meeting Presentation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 19, 2024 NANOVIBRONIX, Inc. By: /s/ Stephen Brown Name: Stephen Brown Title: Chief Financial Officer